|
[1]
|
Eusebi, L.H., Ratnakumaran, R., Yuan, Y., et al. (2018) Global Prevalence of, and Risk Factors for Gastro-Oesophageal Reflux Symptoms: A Meta-Analysis. Gut, 67, 430-440. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sharma, P. and Yadlapati, R. (2021) Pathophysiology and Treatment Options for Gastroesophageal Reflux Disease: Looking be-yond Acid. Annals of the New York Academy of Sciences, 1486, 3-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Vakil, N., van Zanten, S.V., Kahrilas, P., et al. (2006) The Montreal Defi-nition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. The American Journal of Gastroenterology, 101, 1900-1920. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
汪忠镐, 吴继敏, 胡志伟, 等. 中国胃食管反流病多学科诊疗共识[J]. 中华胃食管反流病电子杂志, 2020, 7(1): 1-28.
|
|
[5]
|
Ihde, G.M. (2020) The Evolution of TIF: Tran-soral Incisionless Fundoplication. Therapeutic Advances in Gastroenterology, 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Tack, J. and Pandolfino, J.E. (2018) Pathophysiology of Gas-troesophageal Reflux Disease. Gastroenterology, 154, 277-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chang, K.J. and Bell, R. (2020) Transoral Incisionless Fundopli-cation. Gastrointestinal Endoscopy Clinics of North America, 30, 267-289. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bazerbachi, F., Krishnan, K. and Abu Dayyeh, B.K. (2019) Endo-scopic GERD Therapy: A Primer for the Transoral Incisionless Fundoplication Procedure. Gastrointestinal Endoscopy, 90, 370-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Testoni, S.G.G., Cilona M.B., Mazzoleni, G., et al. (2022) Transoral Incisionless Fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for the Treatment of Gas-tro-Esophageal Reflux Disease: Outcomes Up to 3 Years. Surgical Endoscopy, 36, 5023-5031. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bell, R.C.W., Freeman, K., Heidrick, R., et al. (2021) Transoral Incisionless Fundoplication Demonstrates Durability at Up to 9 Years. Therapeutic Advances in Gastroenterology, 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Choi, A.Y., Roccato, M.K., Samarasena, J.B., et al. (2021) Novel Interdisciplinary Approach to GERD: Concomitant Laparoscopic Hiatal Hernia Repair with Transoral Incisionless Fundoplication. Journal of the American College of Surgeons, 232, 309-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cadière, G., Van Sante, N., Graves, J.E., et al. (2009) Two-Year Results of a Feasibility Study on Antireflux Transoral Incisionless Fundoplication Using EsophyX. Surgical Endoscopy, 23, 957-964. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Testoni, P.A., Corsetti, M., Di Pietro, S., et al. (2010) Effect of Transoral Incisionless Fundoplication on Symptoms, PPI Use, and pH-Impedance Refluxes of GERD Patients. World Journal of Surgery, 34, 750-757. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ihde, G.M., Besancon, K. and Deljkich, E. (2011) Short-Term Safety and Symptomatic Outcomes of Transoral Incisionless Fundoplication with or without Hiatal Hernia Repair in Pa-tients with Chronic Gastroesophageal Reflux Disease. The American Journal of Surgery, 202, 740-747. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Testoni, P.A., Vailati, C., Testoni, S., et al. (2012) Transoral Incisionless Fundoplication (TIF 2.0) with EsophyX for Gastroesophageal Reflux Disease: Long-Term Results and Findings Affecting Outcome. Surgical Endoscopy, 26, 1425-1435. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hunter, J.G., Kahrilas, P.J., Bell, R.C.W., et al. (2015) Efficacy of Transoral Fundoplication vs Omeprazole for Treatment of Regurgitation in a Randomized Controlled Trial. Gastroenter-ology, 148, 324-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Trad, K.S., Fox, M.A., Simoni, G., et al. (2017) Transoral Fun-doplication Offers Durable Symptom Control for Chronic GERD: 3-Year Report from the TEMPO Randomized Trial with a Crossover Arm. Surgical Endoscopy, 31, 2498-2508. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chimukangara, M., Jalilvand, A.D., Melvin, W.S., et al. (2019) Long-Term Reported Outcomes of Transoral Incisionless Fundoplication: An 8-Year Cohort Study. Surgical Endoscopy, 33, 1304-1309. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Trad, K.S., Barnes, W.E., Simoni, G., et al. (2015) Transoral Inci-sionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months. Surgical Innovation, 22, 26-40. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Sami Trad, K. (2016) Transoral Incisionless Fundoplication: Cur-rent Status. Current Opinion in Gastroenterology, 32, 338-343. [Google Scholar] [CrossRef]
|
|
[21]
|
Trad, K.S., Barnes, W.E., Prevou, E.R., et al. (2017) The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-Effective. Surgical Innovation, 25, 149-157. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
McCarty, T.R., Jirapinyo, P., James, L.P., et al. (2022) Transoral Incisionless Fundoplication Is Cost-Effective for Treatment of Gastroesophageal Reflux Disease. En-doscopy International Open, 10, E923-E932. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Gisi, C., Wang, K., Khan, F., et al. (2021) Efficacy and Patient Satisfac-tion of Single-Session Transoral Incisionless Fundoplication and Laparoscopic Hernia Repair. Surgical Endoscopy, 35, 921-927. [Google Scholar] [CrossRef] [PubMed]
|